EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Synthetic Sponge System Against miRNAs of the miR-17/92 Cluster Targets Transcriptional MYC Dosage Compensation in Aneuploid Cancer

Diana M Bravo-Estupiñan iD, Carsten Geiß iD, Jorge L Arias-Arias iD, Mariela Montaño-Samaniego iD, Ricardo Chinchilla-Monge iD, Christian Marín-Müller, Steve Quirós-Barrantes iD, Anne Régnier-Vigouroux, Miguel Ibáñez-Hernández, Rodrigo A Mora-Rodríguez iD

Cells · 2025

DOI: 10.3390/cells14171384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Diana M Bravo-Estupiñan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Doctorado en Ciencias, Sistema de Estudios de Posgrado (SEP), Universidad de Costa Rica, San José 20601, Costa Rica. Hauptthemen laut MEDLINE: MicroRNAs, Aneuploidy, Proto-Oncogene Proteins c-myc, Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vicerrectoría de Investigación, University of Costa Rica, UCREA, Vicerrectoría de Investigación, University of Costa Rica, Alexander von Humboldt foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Genomic instability, a hallmark of cancer, leads to copy number variations disrupting gene dosage balance and contributing to tumor progression. One of the most affected oncogenes is MYC, whose overexpression is tightly regulated to avoid cytotoxicity. In aneuploid cancer cells, gene dosage compensation mechanisms involving microRNAs (miRNAs) from the miR-17/92 cluster contribute in regulating MYC expression. Targeting this miRNA-mediated compensation system represents a promising therapeutic strategy leading to an uncontrolled and lethal MYC overexpression.

Results

Synthetic miRNA sponges targeting miR-17, miR-19a, and miR-20a, key regulators of MYC dosage compensation, were designed and validated. Breast cancer cells (MCF7) with stable exogenous MYC overexpression were used to assess the impact of sponge constructs on MYC regulation. Quantitative RT-PCR revealed a significant reduction in miRNA expression and a corresponding increase in endogenous MYC levels upon sponge treatment. Functional assays in multiple colorectal cancer cell lines with varying MYC copy numbers demonstrated a time-dependent increase in cell death following sponge transfection. Cytotoxic effects increased with MYC copy number, confirming a correlation between gene dosage sensitivity and therapeutic response.

Conclusions

Our findings demonstrate that miRNA sponges targeting the miR-17/92 cluster can effectively disrupt MYC dosage compensation, leading to selective cytotoxicity in MYC-amplified cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsAneuploidyProto-Oncogene Proteins c-mycNeoplasmsHumansGene Expression Regulation, NeoplasticGene DosageCell Line, TumorMCF-7 CellsRNA, Long Noncoding

Stichwörter der Autor:innen

MYCaneuploidycancer gene therapygene dosage compensationgenomic instabilitymiR-17/92 clustermiRNA inhibitionmicroRNA spongesynthetic biologytumor suppressor regulation

Substanzen

MicroRNAsProto-Oncogene Proteins c-mycMIRN17 microRNA, humanMIR17HG, humanMYC protein, humanRNA, Long Noncoding

Autor:innen und Institutionen

  • Programa de Doctorado en Ciencias, Sistema de Estudios de Posgrado (SEP), Universidad de Costa Rica, San José 20601, Costa Rica.
  • Laboratorio de Quimiosensibilidad Tumoral (LQT), Centro de Investigación en Enfermedades Tropicales (CIET), Facultad de Microbiología, Universidad de Costa Rica, San José 20601, Costa Rica.
  • Laboratorio de Terapia Génica, Departamento de Bioquímica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio and Plan de Ayala, Col. Sto Tomás, Miguel Hidalgo, Ciudad de México 11340, Mexic…
  • CICICA, Centro de Investigación en Cirugía y Cáncer, Universidad de Costa Rica, San José 20601, Costa Rica.
  • Centro Nacional de Innovaciones Biotecnológicas (CENIBiot), CeNAT-CONARE, Pavas, San José 10109, Costa Rica.
  • Institute for Developmental Biology and Neurobiology, Johannes Gutenberg University, 55128 Mainz, Germany.

ORCID-Profile: Diana M Bravo-Estupiñan, Carsten Geiß, Jorge L Arias-Arias, Mariela Montaño-Samaniego, Ricardo Chinchilla-Monge, Steve Quirós-Barrantes, Rodrigo A Mora-Rodríguez

Förderung

  • Vicerrectoría de Investigación, University of Costa Rica
  • UCREA, Vicerrectoría de Investigación, University of Costa Rica
  • Alexander von Humboldt foundation

Zitieren

APA

Bravo-Estupiñan, D. M., Geiß, C., Arias-Arias, J. L., Montaño-Samaniego, M., Chinchilla-Monge, R., Marín-Müller, C., Quirós-Barrantes, S., Régnier-Vigouroux, A., Ibáñez-Hernández, M., & Mora-Rodríguez, R. A. (2025). A Synthetic Sponge System Against miRNAs of the miR-17/92 Cluster Targets Transcriptional MYC Dosage Compensation in Aneuploid Cancer. Cells. https://doi.org/10.3390/cells14171384

Vancouver

Bravo-Estupiñan DM, Geiß C, Arias-Arias JL, Montaño-Samaniego M, Chinchilla-Monge R, Marín-Müller C, et al. A Synthetic Sponge System Against miRNAs of the miR-17/92 Cluster Targets Transcriptional MYC Dosage Compensation in Aneuploid Cancer. Cells. 2025. doi:10.3390/cells14171384

BibTeX
@article{BravoEstupian2025,
  author = {Bravo-Estupiñan, Diana M and Geiß, Carsten and Arias-Arias, Jorge L and Montaño-Samaniego, Mariela and Chinchilla-Monge, Ricardo and Marín-Müller, Christian and Quirós-Barrantes, Steve and Régnier-Vigouroux, Anne and Ibáñez-Hernández, Miguel and Mora-Rodríguez, Rodrigo A},
  title = {A Synthetic Sponge System Against miRNAs of the miR-17/92 Cluster Targets Transcriptional MYC Dosage Compensation in Aneuploid Cancer},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14171384}
}
Kostenlos starten →